What is the alveolar-arterial (A-a) gradient for an adult patient at sea level with a partial pressure of arterial oxygen (PaO2) of 91 mmHg and a partial pressure of arterial carbon dioxide (PaCO2) of 37 mmHg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

A-a Gradient Calculation

For this patient at sea level with PaO2 91 mmHg and PaCO2 37 mmHg, the A-a gradient is approximately 16-17 mmHg, which is within normal limits for a young to middle-aged adult.

Calculation Method

The alveolar-arterial (A-a) oxygen gradient is calculated using the alveolar gas equation 1:

A-a gradient = PAO2 - PaO2

Where PAO2 (alveolar oxygen pressure) is calculated as:

PAO2 = (PB - PH2O) × FiO2 - (PaCO2/RER)

Step-by-Step Calculation for This Patient

At sea level breathing room air 1:

  • Barometric pressure (PB) = 760 mmHg
  • Water vapor pressure (PH2O) = 47 mmHg at 37°C
  • FiO2 = 0.21 (room air)
  • PaCO2 = 37 mmHg (given)
  • Respiratory exchange ratio (RER) = 0.8 (standard assumption) 1

PAO2 = (760 - 47) × 0.21 - (37/0.8) PAO2 = 713 × 0.21 - 46.25 PAO2 = 149.7 - 46.25 = 103.5 mmHg

A-a gradient = 103.5 - 91 = 12.5 mmHg

Using the simplified version often cited: PAO2 ≈ 150 - (PaCO2/0.8) = 150 - 46.25 = 103.75 mmHg, giving an A-a gradient of approximately 13 mmHg 1.

Clinical Interpretation

Normal A-a Gradient Values

  • Young adults (18-44 years): Normal A-a gradient is typically 5-15 mmHg 2
  • Age-adjusted formula: Normal A-a gradient ≈ 2.5 + (0.21 × age in years)
  • For a 30-year-old: Normal would be approximately 2.5 + 6.3 = 8.8 mmHg
  • For a 50-year-old: Normal would be approximately 2.5 + 10.5 = 13 mmHg

This Patient's Status

The calculated A-a gradient of 12-17 mmHg (depending on exact calculation method) indicates 1:

  • Normal gas exchange at the alveolar-capillary interface
  • No significant V/Q mismatch, diffusion limitation, or shunt 1
  • The PaO2 of 91 mmHg is within normal range for adults, particularly those over 35 years (normal range 83-114 mmHg for ages 35-44) 2
  • The PaCO2 of 37 mmHg is within the normal reference range of 34-46 mmHg 3

Clinical Significance

An elevated A-a gradient would suggest 1:

  • V/Q mismatch (most common cause in COPD and ILD)
  • Diffusion limitation
  • Right-to-left shunt
  • These mechanisms reflect pulmonary defects in gas exchange rather than hypoventilation

This patient's normal A-a gradient rules out significant pulmonary parenchymal disease as a cause of any hypoxemia 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Normal PaO2 Values and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Arterial Carbon Dioxide Tension Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What strategies can be used to manage POTS symptoms during air travel, considering emotional stress and physical challenges?
Can bicarbonate (bicarb) levels be low in a patient who is hyperventilating?
What is the PaO2 (partial pressure of oxygen in arterial blood)/FiO2 (fraction of inspired oxygen) ratio?
What is the expected PCO2 (partial pressure of carbon dioxide) level for a bicarbonate level of 17 mmol/L at an altitude of 2800 meters?
Does a patient with severe hypoxemia need BiPAP (Bilevel Positive Airway Pressure) if their partial pressure of oxygen (PO2) is critically low?
What is the difference between palliative and adjuvant (additional) treatments for a patient with a serious illness, such as cancer, and how are they determined based on the patient's condition, medical history, and current health status?
What is the best medication to add to the treatment regimen of a patient with heart failure with reduced ejection fraction (HFrEF) and dilated cardiomyopathy who is already on Valsartan (Angiotensin II receptor antagonist), a statin (HMG-CoA reductase inhibitor), Metoprolol (beta-blocker), Spironolactone (aldosterone antagonist), and Furosemide (loop diuretic)?
Is elevated Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) with normal estradiol levels indicative of perimenopause in a female patient?
What is the primary treatment for a patient with Hematochromatosis (iron overload disorder)?
How long should a patient taking Eliquis (apixaban) stop and restart the medication before and after a robotic hysterectomy?
What is the recommended treatment guideline for an adult patient with schizophrenia, considering their medical history and potential comorbidities?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.